Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.

Por Jan Spanholtz, Frank Preijers, Marleen Tordoir, Carel Trilsbeek, Jos Paardekooper, Theo de Witte, Nicolaas Schaap, Harry Dolstra
Publicado em 2011-01-01